Home › NDC Lookup › RxCUI directory › RxCUI 1308428

Everolimus 2 MG Tablet for Oral Suspension — RxCUI 1308428

RxNorm drug concept · Semantic clinical drug
RxCUI 1308428 Semantic clinical drug · SCD ● Current RxNorm concept 20 FDA products 30 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1308428
Official nameEverolimus 2 MG Tablet for Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped20
Package NDCs mapped30
Reported Medicaid activity (SDUD)3,942 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Everolimus: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Afinitor, Yulithira and generic everolimus tablets treat certain cancers and tuberous sclerosis complex conditions. Zortress and generic transplant table...
  • Take it by mouth, the same way every time, either always with food or always without. The cancer and TSC products are usually once a day. The transplant products are usually twice...
  • Mouth sores are very common, along with infections, rash, tiredness, diarrhea, swelling and low appetite. Mention mouth sores early, since they can be managed. Call your doctor rig...
  • Check with me first. Many drugs change everolimus levels, including ketoconazole, clarithromycin, rifampin, St. John’s Wort and certain seizure medicines. Cannabidiol can raise lev...
📖 Read our full Everolimus guide →

🕸️ Concept Web — How Everolimus 2 MG Tablet for Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Everolimus 2 MG Tablet for Oral Suspension RxCUI 1308428

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Everolimus 141704
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Afinitor 845509
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Everolimus Tablet for Oral Suspension 1869513
    • Everolimus Oral Liquid Product 1308426
    • Everolimus Oral Product 1163786
    • Everolimus Tablet for Oral Suspension [Afinitor] 1869516
    • Afinitor Oral Liquid Product 1310137
    • Afinitor Oral Product 1172066
    • Tablet for Oral Suspension 1861409
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Everolimus 2 MG SCDC · 1869512
  • Everolimus Tablet for Oral Suspension SCDF · 1869513
  • Everolimus Oral Liquid Product SCDG · 1308426
  • Everolimus Oral Product SCDG · 1163786

Brand-Name Concepts

  • Everolimus 2 MG Tablet for Oral Suspension [Afinitor] SBD · 1310138
  • Everolimus 2 MG [Afinitor] SBDC · 1869515
  • Everolimus Tablet for Oral Suspension [Afinitor] SBDF · 1869516
  • Afinitor Oral Liquid Product SBDG · 1310137
  • Afinitor Oral Product SBDG · 1172066
  • Afinitor BN · 845509

📦 FDA Products & Package NDCs

20 products · 30 package NDCs
30 package NDCs map to RxCUI 1308428 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00078-0566-51 28 BLISTER PACK in 1 CARTON (0078-0566-51) / 1 TABLET in 1... Afinitor Novartis Pharmaceuticals Corporation 2009-03-31
00078-0567-51 28 BLISTER PACK in 1 CARTON (0078-0567-51) / 1 TABLET in 1... Afinitor Novartis Pharmaceuticals Corporation 2009-03-31
00078-0594-51 28 BLISTER PACK in 1 CARTON (0078-0594-51) / 1 TABLET in 1... Afinitor Novartis Pharmaceuticals Corporation 2010-07-09
00078-0620-51 28 BLISTER PACK in 1 CARTON (0078-0620-51) / 1 TABLET in 1... Afinitor Novartis Pharmaceuticals Corporation 2011-07-29
00078-0626-51 28 BLISTER PACK in 1 CARTON (0078-0626-51) / 1 TABLET, FOR... Afinitor Disperz Novartis Pharmaceuticals Corporation 2012-08-29
00078-0627-51 28 BLISTER PACK in 1 CARTON (0078-0627-51) / 1 TABLET, FOR... Afinitor Disperz Novartis Pharmaceuticals Corporation 2012-08-29
00078-0628-51 28 BLISTER PACK in 1 CARTON (0078-0628-51) / 1 TABLET, FOR... Afinitor Disperz Novartis Pharmaceuticals Corporation 2012-08-29
51991-0821-28 4 BLISTER PACK in 1 CARTON (51991-821-28) / 7 TABLET in 1 B... Everolimus Breckenridge Pharmaceutical, Inc. 2021-03-05
51991-0821-33 30 TABLET in 1 BOTTLE (51991-821-33) Everolimus Breckenridge Pharmaceutical, Inc. 2023-06-05
51991-0822-28 4 BLISTER PACK in 1 CARTON (51991-822-28) / 7 TABLET in 1 B... Everolimus Breckenridge Pharmaceutical, Inc. 2021-03-05
51991-0822-33 30 TABLET in 1 BOTTLE (51991-822-33) Everolimus Breckenridge Pharmaceutical, Inc. 2023-06-05
51991-0823-28 4 BLISTER PACK in 1 CARTON (51991-823-28) / 7 TABLET in 1 B... Everolimus Breckenridge Pharmaceutical, Inc. 2021-03-05
51991-0823-33 30 TABLET in 1 BOTTLE (51991-823-33) Everolimus Breckenridge Pharmaceutical, Inc. 2023-06-05
51991-0824-28 4 BLISTER PACK in 1 CARTON (51991-824-28) / 7 TABLET in 1 B... Everolimus Breckenridge Pharmaceutical, Inc. 2021-10-01
51991-0824-33 30 TABLET in 1 BOTTLE (51991-824-33) Everolimus Breckenridge Pharmaceutical, Inc. 2023-06-05
51991-0990-28 4 BLISTER PACK in 1 CARTON (51991-990-28) / 7 TABLET, FOR S... Everolimus Breckenridge Pharmaceutical, Inc. 2025-01-28
51991-0990-77 28 TABLET, FOR SUSPENSION in 1 BOTTLE (51991-990-77) Everolimus Breckenridge Pharmaceutical, Inc. 2025-07-31
51991-0991-28 4 BLISTER PACK in 1 CARTON (51991-991-28) / 7 TABLET, FOR S... Everolimus Breckenridge Pharmaceutical, Inc. 2025-01-28
51991-0991-77 28 TABLET, FOR SUSPENSION in 1 BOTTLE (51991-991-77) Everolimus Breckenridge Pharmaceutical, Inc. 2025-07-31
51991-0992-28 4 BLISTER PACK in 1 CARTON (51991-992-28) / 7 TABLET, FOR S... Everolimus Breckenridge Pharmaceutical, Inc. 2025-01-28
51991-0992-77 28 TABLET, FOR SUSPENSION in 1 BOTTLE (51991-992-77) Everolimus Breckenridge Pharmaceutical, Inc. 2025-07-31
60219-2279-02 4 BLISTER PACK in 1 CARTON (60219-2279-2) / 7 TABLET, FOR S... EVEROLIMUS Amneal Pharmaceuticals NY LLC 2025-01-14
60219-2280-02 4 BLISTER PACK in 1 CARTON (60219-2280-2) / 7 TABLET, FOR S... EVEROLIMUS Amneal Pharmaceuticals NY LLC 2025-01-14
60219-2281-02 4 BLISTER PACK in 1 CARTON (60219-2281-2) / 7 TABLET, FOR S... EVEROLIMUS Amneal Pharmaceuticals NY LLC 2025-01-14
70377-0090-11 28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-090-11) Everolimus Biocon Pharma Inc. 2026-01-14
70377-0090-23 4 BLISTER PACK in 1 CARTON (70377-090-23) / 7 TABLET, FOR S... Everolimus Biocon Pharma Inc. 2026-01-14
70377-0091-11 28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-091-11) Everolimus Biocon Pharma Inc. 2026-01-14
70377-0091-23 4 BLISTER PACK in 1 CARTON (70377-091-23) / 7 TABLET, FOR S... Everolimus Biocon Pharma Inc. 2026-01-14
70377-0092-11 28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-092-11) Everolimus Biocon Pharma Inc. 2026-01-14
70377-0092-23 4 BLISTER PACK in 1 CARTON (70377-092-23) / 7 TABLET, FOR S... Everolimus Biocon Pharma Inc. 2026-01-14
Observed labelers: Breckenridge Pharmaceutical, Inc. (14) · Novartis Pharmaceuticals Corporation (7) · Biocon Pharma Inc. (6) · Amneal Pharmaceuticals NY LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.